Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy.

已完结 20 由风清扬发布于 2025/8/5 21:41:39

DOI:10.1182/blood.2025029773
作者：Binod Dhakal,Othman Salim Akhtar,David Fandrei,Alexandria Jensen,Rahul Banerjee,Darren Pan,Shambavi Richard,Reed Friend,Matthew James Rees,Patrick Costello,Mariola Alejandra Vazquez Martinez,Oren Pasv
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Ciltacabtagene autoleucel (cilta-cel) and idecabtagene vicleucel (ide-cel), two BCMA-directed chimeric antigen receptor T cell (CAR-T) therapies, have transformed outcomes for relapsed/refra

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Study on Variation of Resonance Frequencies and Mode Shapes for Turbomolecular Pump Rotor Considering Variation of Contact Stiffness of Bolt Joint According to Rotating Speed Change